Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
17. März 2022 07:00 ET
|
Synlogic, Inc.
- Phenylketonuria (PKU) program on track for Phase 3 trial initiation in H2 2022 – - Clinical readouts anticipated for PKU program in H1 2022 and in homocystinuria and enteric hyperoxaluria in H2...